|
MTHFD1L expression based on
|
KIRC : Kidney renal clear cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 2.38349999737153E-08 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
5.24080000507965E-08 |
| Normal-vs-Stage2 |
6.823700E-03 |
| Normal-vs-Stage3 |
6.0210000000005E-05 |
| Normal-vs-Stage4 |
8.15540000000947E-05 |
| Stage1-vs-Stage2 |
5.543400E-01 |
| Stage1-vs-Stage3 |
4.371000E-01 |
| Stage1-vs-Stage4 |
7.535800E-01 |
| Stage2-vs-Stage3 |
9.745200E-01 |
| Stage2-vs-Stage4 |
5.137000E-01 |
| Stage3-vs-Stage4 |
4.135000E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
2.51859999966797E-07 |
| Normal-vs-AfricanAmerican |
1.744579999996E-05 |
| Normal-vs-Asian |
8.321700E-02 |
| Caucasian-vs-AfricanAmerican |
6.149800E-02 |
| Caucasian-vs-Asian |
1.993550E-01 |
| AfricanAmerican-vs-Asian |
3.382200E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
3.33130001362036E-09 |
| Normal-vs-Female |
1.383850E-04 |
| Male-vs-Female |
4.839800E-02 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
3.415400E-03 |
| Normal-vs-Age(41-60Yrs) |
1.56559999964223E-07 |
| Normal-vs-Age(61-80Yrs) |
5.16359999980232E-07 |
| Normal-vs-Age(81-100Yrs) |
1.166240E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
2.754200E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
1.599200E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
8.240000E-02 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
8.420000E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
1.904990E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
2.505200E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
| Subtype descriptions |
| Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
| Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Grade 1 |
3.253900E-02 |
| Normal-vs-Grade 2 |
1.36939999995089E-06 |
| Normal-vs-Grade 3 |
3.04709999998654E-06 |
| Normal-vs-Grade 4 |
1.36240000003784E-06 |
| Grade 1-vs-Grade 2 |
8.233800E-01 |
| Grade 1-vs-Grade 3 |
8.946800E-01 |
| Grade 1-vs-Grade 4 |
8.313800E-02 |
| Grade 2-vs-Grade 3 |
7.593200E-01 |
| Grade 2-vs-Grade 4 |
2.398100E-02 |
| Grade 3-vs-Grade 4 |
1.566120E-02 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-ccA subtype |
2.412500E-02 |
| Normal-vs-ccB subtype |
3.86879417391128E-12 |
| ccA subtype-vs-ccB subtype |
1.53760004728554E-10 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
6.24130000015377E-07 |
| Normal-vs-N1 |
8.719300E-03 |
| N0-vs-N1 |
1.734830E-01 |
|
|
